Spain's Sanifit Developing Unique Microcrystal Inhibitor For Calcification In Renal Disease
This article was originally published in The Pink Sheet Daily
Executive Summary
Preventing cardiovascular disease associated with calcification in end-stage renal disease is the target for a potential first-in-class inhibitor of microcrystal formation that has attracted venture capital from across Europe.